Sharon Mates
Insider
IndividualSelling only8 10b5-1 trades
- 2024
- May 4, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sharon Mates files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SUVRETTA CAPITAL MANAGEMENT, LLC - $22.44M in BNTC purchases and sales in the last 12 months
- ARCH Venture Partners XII, LLC - $19.80M in SPTX purchases and sales in the last 12 months
- Robert J. Hombach - $236K in SPTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sharon Mates?
Sharon Mates is a corporate insider of Seaport Therapeutics, Inc. (SPTX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Sharon Mates last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 5 filings going back to 2024.
Has Sharon Mates been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($8.72M) across all tracked filings.
